| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $8.75 ▲ +1.94% | wingi | $8.51 ▼ -0.82% | Sesuk Bio Cryst Pharmaceuticals Inc. Common Stock (BCRX) persiyapan wis anchored kanggo $8.58 lan target $8.75 (+1.94%). Waca sing cedhak yaiku munggah; nonton $8.84 / $8.32 amarga volatilitas sing diwujudake saben dina babagan 8.00%. |
Sesuk Bio Cryst Pharmaceuticals Inc. Common Stock (BCRX) persiyapan wis anchored kanggo $8.58 lan target $8.75 (+1.94%). Waca sing cedhak yaiku munggah; nonton $8.84 / $8.32 amarga volatilitas sing diwujudake saben dina babagan 8.00%. | ||||
| Minggu | $9.10 ▲ +6.05% | Minggu kepungkur | $8.36 ▼ -2.54% | Model 7 dina Bio Cryst Pharmaceuticals Inc. Common Stock pindhah saka $8.36 menyang $9.10 (+6.05%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $8.84 / $8.32 prakara luwih saka siji obah. |
Model 7 dina Bio Cryst Pharmaceuticals Inc. Common Stock pindhah saka $8.36 menyang $9.10 (+6.05%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $8.84 / $8.32 prakara luwih saka siji obah. | ||||
| wulan | $9.69 ▲ +12.89% | Wulan kepungkur | $8.12 ▼ -5.41% | Target 1 wulan Bio Cryst Pharmaceuticals Inc. Common Stock yaiku $9.69 (+12.89%), dibandhingake karo referensi langsung ing cedhak $8.58. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Bio Cryst Pharmaceuticals Inc. Common Stock yaiku $9.69 (+12.89%), dibandhingake karo referensi langsung ing cedhak $8.58. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $10.56 ▲ +23.13% | Taun kepungkur | $7.75 ▼ -9.72% | Skenario 1 taun Bio Cryst Pharmaceuticals Inc. Common Stock nuduhake $10.56 (+23.13%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Bio Cryst Pharmaceuticals Inc. Common Stock nuduhake $10.56 (+23.13%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $12.62 ▲ +47.14% | 5 Taun kepungkur | $6.88 ▼ -19.80% | Tampilan 5 taun Bio Cryst Pharmaceuticals Inc. Common Stock yaiku $12.62 (+47.14%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Bio Cryst Pharmaceuticals Inc. Common Stock yaiku $12.62 (+47.14%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $8.58 | agêng |
| Ganti saben dina | -6.64% | Ngisor |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 72% | Ndhuwur |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $8.58 | Ganti saben dina | -6.64% |
| Pasar Kab | $2.15B | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.